Enduring Materials

Monographs and Journal Supplements

Knowledge Is Power: Two CE-Certified Monographs for Nurses and Nurse Practitioners
Discuss the public health implications of untreated heart failure; describe the pathophysiology, stages, and diagnosis of heart failure; and more... learn more

Newsletters

Weekly Literature Update for Impact Faculty, April 7, 2007

Podcasts

New Perspectives and Controversies in Cardiology: A CME-certified Webinar from the 2005 American Heart Association Satellite Symposium
→ Ileana L. Piña, MD (7.9MB)
→ Prakash Deedwania, MD (7.1MB)
→ Keith C. Ferdinand, MD & JoAnn Lindenfeld, MD (7.2MB)
→ Mandeep R. Mehra, MD (9.7MB)

Web-based Activities

Rethinking Asthma Control:
Integrating the New Guidelines for Asthma Management
In this presentation, we will explore some of the many challenges of asthma–how to diagnose it, why it's important to understand the nature of its progression, and how to identify which of our patients are most at risk. We will also address the latest recommendations for classifying our asthma patients and discuss some of the tools for assessing asthma, both current ones and those in development. learn more

ePocrates MobileCME™
INNOVIA Education Institute, LLC, collaborates with Epocrates, Inc., to develop CME-certified mobile and web-based activities to provide physicians with drug, disease, and diagnostic information at the point of care. To learn more about Epocrates CME, please click the link.

Medscape™ CME Circle
INNOVIA Education Institute, LLC, works with Medscape to develop CME-certified online content, typically from live symposia or monographs, which is posted on Medscape and archived for one year.

CD-ROMs

New Perspectives and Controversies in Cardiology
Adapted from a CME satellite symposium at the American Heart Association's Scientific Sessions 2005*

For decades, research efforts related to cardiovascular disease risk and prevention did not account for differences in patient populations. We now know that patients with such comorbidities as diabetes and the metabolic syndrome, as well as women, the elderly, and patients from various ethnic groups, have different cardiovascular disease risks and require special consideration. A sizable body of evidence supports the use of beta blockers and angiotensin receptor blockers (ARBs) in hypertension and HF in the general population. However, until recently, their benefit in specific populations had not been as well defined.

*This symposium was not part of the official Scientific Sessions 2005 as planned by the AHA Committee on Scientific Sessions Program.